Clinical Trials Browser

Blood Specimen Collection × Clear all

NCT02453620 2026-03-18

Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer

Phase 1 Active not recruiting

BreastOther solid neoplasm

Anatomic Stage III Breast Cancer AJCC v8

NCT02867033 2026-03-18

ALTITUDES

Phase NA Active not recruiting

Desmoid Tumors

NCT05435495 2026-03-18

Mechanisms of Resistance to PSMA Radioligand Therapy

Prostatic Neoplasms

NCT07151118 2026-03-18

ctDNA in Genetic Profiling and Clinical Outcomes of Advanced Biliary Tract Cancer

Gastrointestinal

Biliary Tract Neoplasms

NCT07163507 2026-03-18

RICEPS-2

Phase NA Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05964504 2026-03-17

Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)

Breast Neoplasms, Carcinoma, Lobular

NCT07475923 2026-03-17

Molecular Surveillance In Early Breast Cancer Using The Tumor-Informed ctDNA Assay Myriad Genetics Precise MRD Test; A Prospective Observational Multicenter Study (The MRD Molecular Surveillance Study)

Not yet recruiting

Breast Neoplasms

NCT07476781 2026-03-17

CSF and Blood Plasma Liquid Biopsy in Patients With Metastatic Solid Tumours and CNS Metastases or no CNS Metastases

Phase NA Recruiting

Meningeal Neoplasms

NCT07477769 2026-03-17

NIPALYMPHO

Not yet recruiting

Sezary Syndrome, Ichthyosis, Lamellar

NCT07478016 2026-03-17

EXIST

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT04767568 2026-03-16

PREDICT-IRFC

Phase NA Recruiting

Gastrointestinal

Colorectal Neoplasms

NCT06796114 2026-03-16

PREDICT-HCC

Phase NA Recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT07472387 2026-03-16

Andro-iGlio

Phase NA Not yet recruiting

Glioblastoma

NCT01046487 2026-03-13

PALANGI3

Phase 1 Completed

DermatologicGastrointestinalSarcoma

Uveal Melanoma, Chordoma, Carcinoma, Adenoid Cystic, Neoplasms, Desmoid Tumors, Dermatofibrosarcoma, Gastrointestinal Stromal Tumors

NCT01647867 2026-03-13

MetLung

Phase NA Completed

Carcinoma, Non-Small-Cell Lung

NCT07469319 2026-03-13

BISHOP

Phase NA Recruiting

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular

NCT03249389 2026-03-12

CALCIOBS

Phase NA Completed

Breast Neoplasms

NCT03252912 2026-03-12

LCS Bio Sein

Phase NA Completed

Breast Neoplasms

NCT04953312 2026-03-12

CALPRO

Phase NA Withdrawn

MyeloidOther hematologic neoplasm

COVID-19, Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic

NCT06349642 2026-03-12

ELEPHAS-04

DermatologicGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Clear-cell metastatic renal cell carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinosarcoma, Uterine Cervical Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Neoplasm Metastasis, Skin Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT07465848 2026-03-12

PneumoTAV001

Phase NA Recruiting

Disease, Lung Neoplasms

NCT07467109 2026-03-12

A Study to Evaluate the Safety and Efficacy of Intracranial Venous Blood Sampling for Liquid Biopsy in the Diagnosis of Brain Cancers

Not yet recruiting

Brain Neoplasms

NCT07463508 2026-03-11

TG-BIL

Phase NA Recruiting

Testicular Neoplasms

NCT04454528 2026-03-10

BreastVAX

Phase 1/2 Active not recruiting

Breast Neoplasms

NCT06151223 2026-03-10

A Prospective Registry for Patients at High-Risk for Pancreatic Cancer

Gastrointestinal

Pancreatic Neoplasms

NCT06274515 2026-03-09

REMERGE

Phase 4 Recruiting

Breast Neoplasms

NCT06510868 2026-03-05

MDS & PRRT

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT07046936 2026-03-03

MITO-RES

Neoplasms

NCT07447076 2026-03-03

Study of Novel Therapies for Young People With Recurrent/Progressive Atypical Teratoid Rhabdoid Tumor (ATRT)

Phase 2 Not yet recruiting

Rhabdoid Tumor

NCT03830320 2026-02-27

Positron Emission Tomography (PET) Imaging of Thrombosis

Phase 1 Recruiting

COVID-19, Atrial Fibrillation, Neoplasms, Thrombosis

NCT06480591 2026-02-25

Evaluation of the Pathobiology of CALR-mutated MPN Cells

Myeloproliferative Disorders, Thrombosis

NCT07422805 2026-02-24

ctDNA

Phase NA Completed

Melanoma, Skin Neoplasms

NCT06572735 2026-02-23

PARIB-OLD-PRO²

Neoplasms, Ovarian Neoplasms

NCT07422974 2026-02-20

Neocolon

Gastrointestinal

Colorectal Neoplasms

NCT05595577 2026-02-19

PALS

Phase NA Recruiting

Breast Neoplasms, Hodgkin Disease, Lymphoma, Non-Hodgkin

NCT06127979 2026-02-19

A Study of Changes in Ki67 Expression in People With Breast Cancer Receiving Endocrine Therapy Before Surgery

Phase NA Recruiting

Breast Neoplasms

NCT07421479 2026-02-19

PDO-Mercurial

Active not recruiting

Triple Negative Breast Neoplasms

NCT02324062 2026-02-18

HCP

BreastGynecologic

Hereditary Breast and Ovarian Cancer Syndrome

NCT07342179 2026-02-18

CART I5M

Phase NA Recruiting

Multiple Myeloma

NCT01728402 2026-02-17

Pathogenesis of Hematologic Malignancies

Enrolling by invitation

LymphoidMyeloid

Lymphoproliferative Disorders, Myelodysplastic Syndromes, Myeloproliferative Disorders

NCT04925089 2026-02-17

Localized Leiomyosarcoma Biomarker Protocol

Leiomyosarcoma

NCT01915797 2026-02-13

TED

Neoplasms

NCT06929013 2026-02-13

NUCLEAR

Phase NA Recruiting

Peritoneal Neoplasms

NCT07033091 2026-02-13

Prevalence of Human Papillomavirus (HPV) in a Healthy Population: A Feasibility Study of Oropharyngeal Cancer Screening

Phase NA Recruiting

20,000 enrolled

Oropharyngeal Neoplasms, Papillomavirus Infections

NCT07406646 2026-02-12

EXO-RENAL1

Phase NA Completed

Carcinoma, Renal Cell

NCT06071286 2026-02-11

SPEED

Phase NA Recruiting

Ovarian Neoplasms

NCT00349830 2026-02-10

Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy

Adenocarcinoma, Carcinoma, Neoplasms

NCT07401355 2026-02-10

LIGHT-CTC

Phase NA Not yet recruiting

Neoplasms, Sarcoma

NCT01966081 2026-02-09

AGARIC

Phase NA Completed

Gastrointestinal

First Recently-diagnosed Colorectal Cancer

NCT07398170 2026-02-09

BIOLIMEN-1

Phase NA Not yet recruiting

Meningioma, Neoplastic Cells, Circulating, Neoplasm Recurrence, Local